Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

174 G/C interleukin 6 genotype is related to higher risk of graft loss and GFR decline in 5-year observation in kidney graft recipients

U Siekiera, J Chudek, A Kolonko, M Szotowska, H Karkoszka, L Cierpka, A Więcek

Ann Transplant 2009; 14(1): 38-38 :: ID: 880336

Abstract

Background: Polymorphisms of TNF-alfa, IL-10, IL-6, IFN-gamma and TGF-b1
genes are related to the constitutional gene expression and production of appropriate cytokines. The aim of this study was to assess the impact of TNF-alfa, IL-10, IL-6, and IFN-gamma genotypes on GFR and long-term kidney graft outcome.
Material/Methods: Genotyping was performed in 240 subsequent kidney graft recipients from 1998 to 2002. Genomic DNA was obtained from peripheral leukocytes. Identification of cytokine genotypes was based on PCR-SSP  method for TNF-alfa at position -308 A/G, IL-10 at positions -1082 A/G, -819 T/C, -592 A/C, IL-6 at position -174 G/C, IFN-gamma at position +874 T/A and TGFb1in codon 10 (T/C) and 25 (G/C). Genotypes were grouped according to the strength of cytokines expression. Nineteen patients with primary graft nonfunction were excluded from the analysis. During 5-year follow up period 17 patients died with functioning graft and 35 patients developed graft failure. Glomerular filtration rate (eGFR) was estimated based on MDRD equation. The yearly eGFR decline was calculated from 6 months to 5 years follow-up period.
Results: Only IL-6 gene polymorphism had signifi cant impact on kidney graft
survival and decline of eGFR. In patients with CC genotype (determining low IL-6 production) only 6 out of 68 patients (8.8%) lost kidney graft while in the group with GG and GC genotypes (determining higher IL-6 production) 29 out of 151 patients (19.2%). The risk of graft loss (hazard ratio) was 2.38 (1.01-4.16), p=0.046 for GG or GC carriers. The frequency of death was
similar in both groups (7.3 and 7.9%). eGFR decline was significantly faster
in GG or GC carriers [-4.61 (-6.01- -3.21) ml/min/year] than CC carriers
[-2.07 (-3.27- -0.88) ml/min/year], p=0.02.
Conclusions: IL-6 genotypes of the kidney recipient, determining higher IL-6
constitutional expression, are related to the increased risk of graft loss.

Keywords: Kidney Transplantation

Add Comment 0 Comments

In Press

Original article  

Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...

Ann Transplant In Press; DOI: 10.12659/AOT.951568  

Original article  

Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.950589  

Database Analysis  

Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...

Ann Transplant In Press; DOI: 10.12659/AOT.950289  

Original article  

Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...

Ann Transplant In Press; DOI: 10.12659/AOT.950997  

Most Viewed Current Articles

24 Aug 2021 : Review article   18,372

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

05 Apr 2022 : Original article   14,731

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   14,244

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

29 Dec 2021 : Original article   13,752

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358